期刊文献+

脆性组氨酸三聚体蛋白和蛋白激酶Cα的表达及其与非小细胞肺癌侵袭、转移的相关性 被引量:1

A study on the correlation between FHIT protein and cPKCα expression and invasion and metastasis in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨脆性组氨酸三聚体(FHIT)蛋白和蛋白激酶Cα(cPKCα)在非小细胞肺癌(NSCLC)中的表达及其与NSCLC侵袭、转移的相关性。方法采用免疫组化PicTureTM通用型二步法,对41例NSCLC组织和11例肺良性病变组织行FHIT蛋白和cPKCα检测。结果FHIT蛋白和cPKCα在NSCLC组织中的阳性表达率分别为48.8%和53.7%,在肺良性病变组织中的阳性表达率分别为90.9%和18.20%,均有显著性差异(P<0.05);COX比例风险模型生存分析结果显示,FHIT蛋白(P=0.020,RR=2.754)、cPKCα(P=0.022,RR=0.385)具有独立的预后意义。结论FHIT蛋白和cPKCα表达与NSCLC的发展、侵袭及转移显著相关,可作为判断NSCLC临床预后的参考指标。 Objective To investigate the role of FHIT protein and cPKCa in invasion and metastasis in non- small cell lung cancer (NSCLC). Methods The expression of FHIT protein and cPKCa in 41 specimens of NSCLC and 11 cases benign lung tissues were examined by immunohistochemical technique. Results The positive rate of FHIT protein and cPKCa in NSCLC tissues were 48.8% and 53.7% respectively. The positive rate of FHIT protein and cPKCa in benign lung tissues were 90.9% and 18.2% respectively. They were significantly different (P〈0.05). The results of the proportioned hazards regression model (Cox model) showed that FHIT protein (P= 0. 020, RR =2. 754), cPKCa ( P=0. 022, RR =0. 385) were independent prognosis factors of NSCLC. Conclusion The expression of FHIT protein and cPKCa were closely related to the invasion and metastasis of NSCLC. The examination of FHIT protein and cPKCa would be independent factors which had correlation with prognosis of NSCLC.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第4期352-355,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 非小细胞肺癌 脆性组氨酸三聚体(FHIT) 蛋白激酶Ca(cPKCa) 侵袭 免疫组化 NSCLC FHIT cPKCa invasion immunohistochemistry
  • 相关文献

参考文献12

  • 1Ohta,Inoue H,Cotticelli MG,et al.The FHIT gene,spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint,is abnormal in digestive tract cancers[J].Cell,1996,84(4):587-597.
  • 2Sozzi G,Veronese ML,Negrini M,et al.The FHIT gene 3p14.2 is abnormal in lung cancer[J].Cell,1996,85(1):17-26.
  • 3Cheng S,Gao Y,Dong X,et al.Molecular and cytogenetic alterations in early stage of carcinogenesis of human lung[J].Cancer Lett,2001,162(Suppl):S5-S10.
  • 4Tomizawa Y,Nakajima T,Kohno T,et al.Clinicopathological significance of FHIT protein in expression in stageⅠnonsmall cell lung carcinoma[J].Cancer Res,1998,58(23):5478-5483.
  • 5Zanesi N,Pekarsky Y,Croce CM.A mouse model of the fragile gene FHIT:From carcinogenesis to gene therapy and cancer prevention[J].Murat Res,2005,591(1-2):103-109.
  • 6Sharkey NA,Leach KL,Blumerg PM.Competitive inhibition by diacylglycerol of specific phorol ester binding[J].Proc Natl Acad Sci USA,1984,81(2):607-610.
  • 7周清华,刘伦旭,李潞,王允,陈军,杨金龙.PKC基因在人肺癌中的转录表达[J].中国肺癌杂志,2000,3(5):351-354. 被引量:9
  • 8Pearson JD,DeWald DB,Mathews WR,et al.Amino acid sequence and characterization of a protein inhibitor of protein kinase C[J].J Biol Chem,1990,265(8):4583-4591.
  • 9Brzoska PM,Chen H,Zhu Y,et al.The product of the ataxiatelangiectasia group D complementing gene,ATDC,interacts with a protein kinase C substrate and inhibitor[J].Proc Natl Acad Sci USA,1995,92(17):7824-7828.
  • 10Huebner K,Garrison PN,Barnes LD,et al.The role of the FHIT/FRA3B locus in cancer[J].Annu Rev Genet,1998,32:7-31.

二级参考文献8

共引文献9

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部